Pamela G. Coxson | Academic Influence

Pamela G. Coxson's AcademicInfluence.com Rankings

Pamela G. Coxson

Mathematics

#4324

World Rank

#6168

Historical Rank

#1508

USA Rank

Measure Theory

#3550

World Rank

#4190

Historical Rank

#1027

USA Rank

mathematics Degrees

Download Badge

Mathematics

Pamela G. Coxson's Degrees

PhD Mathematics University of California, Berkeley
Masters Mathematics University of California, Berkeley
Bachelors Mathematics University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Pamela G. Coxson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Pamela Gail Coxson is an American applied mathematician specialized in disease modelling. She is a specialist in the division of general and internal medicine at the University of California, San Francisco Center for Vulnerable Populations.

(See a Problem?)

Pamela G. Coxson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Projected effect of dietary salt reductions on future cardiovascular disease. (2010) (1165)
Adolescent overweight and future adult coronary heart disease. (2007) (540)
Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. (1987) (393)
Future Cardiovascular Disease in China: Markov Model and Risk Factor Scenario Projections From the Coronary Heart Disease Policy Model–China (2010) (357)
Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. (2002) (302)
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease. (2016) (285)
Cost-effectiveness of hypertension therapy according to 2014 guidelines. (2015) (211)
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering (2009) (204)
A penny-per-ounce tax on sugar-sweetened beverages would cut health and cost burdens of diabetes. (2012) (201)
Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies (1991) (188)
The impact of the aging population on coronary heart disease in the United States. (2011) (172)
Cost-Effectiveness of Statin Therapy for Primary Prevention in a Low-Cost Statin Era (2011) (169)
Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. (2011) (165)
Projected Impact of Mexico’s Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study (2016) (129)
Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. (2009) (123)
Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial (2017) (123)
Positive Input Reachability And Controllability Of Positive Systems (1987) (111)
Health and Economic Benefits of Increased β-Blocker Use Following Myocardial Infarction (2000) (106)
Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease: effect of grain fortification and beyond. (2001) (105)
The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China (2008) (96)
Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States (2015) (81)
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. (2001) (74)
Lumping strategy. 1. Introductory techniques and applications of cluster analysis (1987) (73)
The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study (2015) (65)
Consequences of using a simplified kinetic model for dynamic PET data. (1997) (65)
Mortality Benefits From US Population-wide Reduction in Sodium Consumption: Projections From 3 Modeling Approaches (2013) (61)
6-[18F]Fluoro-l-m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates (1997) (57)
Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults. (2020) (55)
Health Benefits of Reducing Sugar-Sweetened Beverage Intake in High Risk Populations of California: Results from the Cardiovascular Disease (CVD) Policy Model (2013) (54)
Health and economic benefits of increased beta-blocker use following myocardial infarction. (2000) (52)
Response to mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches. (2013) (52)
Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China (2017) (40)
Projected impact of urbanization on cardiovascular disease in china (2012) (38)
Cost-Effectiveness of Optimal Use of Acute Myocardial Infarction Treatments and Impact on Coronary Heart Disease Mortality in China (2014) (38)
Cost-Effectiveness of Alirocumab (2019) (32)
Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law (2012) (32)
The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines. (1999) (32)
Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35–74 Years: The Cardiovascular Disease Policy Model (2016) (31)
Cost-effectiveness of PCSK 9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease (2016) (30)
Monomial patterns in the sequence Akb (1987) (30)
Coronary heart disease attributable to passive smoking: CHD Policy Model. (2009) (29)
Simulation of compartmental models for kinetic data from a positron emission tomograph. (1992) (28)
Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study (2016) (27)
Lumping strategy. II: A system theoretic approach (1987) (25)
Simulating Strategies for Improving Control of Hypertension Among Patients with Usual Source of Care in the United States: The Blood Pressure Control Model (2015) (24)
Projected Impact of a Sodium Consumption Reduction Initiative in Argentina: An Analysis from the CVD Policy Model – Argentina (2013) (23)
Lumpability and Observability of Linear Systems (1984) (23)
Using Stress Testing to Guide Primary Prevention of Coronary Heart Disease Among Intermediate-Risk Patients: A Cost-Effectiveness Analysis (2012) (22)
Coronary heart disease and stroke attributable to major risk factors is similar in Argentina and the United States: the Coronary Heart Disease Policy Model. (2011) (21)
Abstract MP43: The Population Impact and Cost-Effectiveness of Statins for Primary Prevention in Adults 75 and Older in the United States (2014) (20)
Variability and reproducibility of rubidium-82 kinetic parameters in the myocardium of the anesthetized canine. (1995) (19)
Kinetic analysis of rubidium and thallium as deposited myocardial blood flow tracers in isolated rabbit heart. (1997) (18)
Projected impact of a reduction in sugar-sweetened beverage consumption on diabetes and cardiovascular disease in Argentina: A modeling study (2020) (16)
Cost-Effectiveness of Hypertension Treatment by Pharmacists in Black Barbershops (2021) (12)
The Cardiovascular Health Burdens of Solitary Confinement (2019) (10)
Cardiovascular and diabetes burden attributable to physical inactivity in Mexico (2020) (9)
Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study. (2016) (8)
Comparing Strategies for Lipid Lowering in Argentina: An Analysis from the CVD Policy Model–Argentina (2017) (7)
Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study (2016) (7)
Volume-of-interest specification on arbitrarily resliced volume datasets (1995) (6)
[The cost-utility ratio of reducing salt intake and its impact on the incidence of cardiovascular disease in Argentina]. (2012) (6)
Effect of Money-Back Guarantees on the Cost-Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (2018) (6)
Conditions for scale-based decompositions in singularly perturbed systems (1988) (5)
Scaling Up Pharmacist-Led Blood Pressure Control Programs in Black Barbershops: Projected Population Health Impact and Value. (2021) (5)
Update of the cardiovascular disease policy model to predict cardiovascular events in Argentina. (2019) (4)
Consolidation Of Common Parameters In Dynamic PET Data Analysis (1990) (4)
Consolidation of common parameters from multiple fits in dynamic PET data analysis (1997) (4)
Model reduction: Identifying partitions for structured aggregates (1985) (4)
Time Scale Decomposition: The Role of Scaling in Linear Systems and Transient States in Finite-State Markov Processes (1985) (3)
Abstract 24: From JNC 1 to JNC 8: Population Impact and Cost-Effectiveness of U.S. Hypertension Guidelines (2015) (2)
Structured model reduction (1984) (2)
Comparative cost-effectiveness of conservative or intensive blood pressure treatment guidelines in adults aged 35-74 years : the CVD Policy Model (2016) (2)
Comparison of kinetic models for data from a positron emission tomograph (1995) (2)
Strategies for extraction of quantitative data from volumetric dynamic cardiac positron emission tomography data. (1997) (2)
Abstract 14053: Scaling up a Pharmacist-Led Blood Pressure Control Program In Black Barbershops: Projecting Population Health Impact and Cost-Effectiveness (2019) (2)
Abstract 069: Missed Opportunities For The Control Of Hypertension In Premenopausal Women In The US (2022) (1)
Abstract 13699: Cardiovascular Health Impact of Air Pollution Control in Beijing and Urban China: Projections From the Cardiovascular Disease Policy Model-China (2015) (1)
Does age modify effectiveness of statin therapy in coronary artery disease? (2010) (1)
Abstract T MP100: Improving Encounter Frequency, Physician Prescribing, or Patient Adherence - What Works Best for Controlling Blood Pressure? Results From a Validated Micro-Simulation Model (2014) (1)
Abstract MP019: Should Global Cardiovascular Risk Guide Treatment of Stage One Hypertension? A Cost-effectiveness Analysis (2012) (1)
Review of Nonnegative matrices in dynamic systems: by A. Berman, M. Neuman, and R.J. Stern☆ (1991) (0)
Abstract P032: Initiating Hypertension Treatment To Prevent Incident Cardiovascular Disease: A Population Estimate Using The Cardiovascular Disease Policy Model (2022) (0)
A note on memoryless operators (1983) (0)
Abstract 4008: The Burden of Coronary Heart Disease Attributable to Passive Smoking Remains Large (2006) (0)
Strategies for Extraction of Quantitative Data from Volumetric Dynamic Cardiac PET Data (2013) (0)
Strategies for Extraction of Quantitative Data from Volumetric Dynamic Cardiac PET Data (2013) (0)
Lumping analysis in the presence of measurement error (1987) (0)
Abstract 18899: Cardiovascular Benefits of Dietary Salt Reduction for US Adolescents (2010) (0)
Abstract 616: The Population Impact and Cost-Effectiveness of Blood Pressure Treatment in U.S. Adults Age 75 and Older (2013) (0)
GW24-e2168 Cost-effectiveness of Improving Acute Myocardial Infarction Treatments and the impact on mortality rate of coronary heart disease in China (2013) (0)
Controlability of positive systems (1985) (0)
Abstract P043: National Trends in Hypertension Control 1999-2012 and Projected Impact on Incident Stroke by Age, Sex, and Race: The Cardiovascular Disease Policy Model (2014) (0)
Abstract P113: Increasing Fruit And Vegetable Intake Prevents Incident Cardiovascular Disease And Cardiovascular Deaths (2022) (0)
Abstract 16987: Simulation Modeling to Inform Future Population Health Interventions to Decrease the Burden of Cardiovascular Disease in the United States (2016) (0)
A Strategy For Using Closed Form Solutions For Compartmental Models Of Dynamic PET Data (1990) (0)
Abstract P482: Long-term Health and Cost Impact of the 2017 American College of Cardiology/American Heart Association (2017 Acc/aha) Hypertension Guidelines for Low-risk Adults (2020) (0)
Abstract P013: Cost-Effectiveness of Treating Hypertension in African Americans According to 2014 Guidelines (2015) (0)
Dipyridamole-induced stress - variability in {sup 82}Rb PET kinetic studies in the anesthetized canine (1996) (0)
COST-EFFECTIVE PRIMARY PREVENTION OF CORONARY HEART DISEASE IN INTERMEDIATE RISK PATIENTS: UNIVERSAL ASPIRIN AND STATINS IS SUPERIOR TO PREVENTION GUIDED BY STRESS TESTING (2010) (0)
Cluster Analysis and Lumpability of Large Linear Systems (1986) (0)
Abstract 4103: Projected Increase in Rates of Future Adult Coronary Heart Disease Associated with Current Adolescent Obesity (2006) (0)
Abstract WP158: Case Fatality and Risk Factor Trend Contributions to Stroke Mortality in Non-Hispanic Blacks and Non-Hispanic Whites, 1999-2012 (2016) (0)
Abstract 10125: Increasing Encounter Frequency, Physician Prescribing, or Patient Adherence - What Works Best for Controlling Blood Pressure?: Results From a New Simulation Model (2012) (0)
Health Affairs Cost Burdens Of Diabetes A Penny-Per-Ounce Tax On Sugar-Sweetened Beverages Would Cut Health And (2012) (0)
Abstract P308: Comparative Cost-effectiveness Of Hypertension Treatment Guidelines In US Adults (2022) (0)
August , 1984 LIDS-P-1400 Model Reduction : Identifying Partitions for Structured Aggregates (0)
ForecastingtheFutureEconomicBurdenofCurrent AdolescentOverweight:AnEstimateoftheCoronary HeartDiseasePolicyModel (2009) (0)
Health and Economic Benefits of Increased (cid:98) -Blocker Use Following Myocardial Infarction (2000) (0)
Abstract 3857: Cost-effectiveness of Aspirin for the Primary Prevention of Coronary Heart Disease (2006) (0)
Abstract 9930: Cost Effectiveness of Improved Acute Myocardial Infarction Treatment in China: Projections From the Coronary Heart Disease Policy Model-China (2011) (0)
{sup 82}Rb kinetic parameter variability due to depth of anesthesia in the anesthetized canine (1995) (0)

This paper list is powered by the following services:

Other Resources About Pamela G. Coxson

en.wikipedia.org

What Schools Are Affiliated With Pamela G. Coxson?

Pamela G. Coxson is affiliated with the following schools: